World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
78
Citations
25787
World Ranking
17932
National Ranking
1634

Richard Freeman publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Richard Freeman sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 350 publications — 28th percentile

28% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Richard Freeman D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Richard Freeman sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 78 D-Index — 12th percentile

12% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

What is he best known for?

The fields of study he is best known for:

  • Law
  • Capitalism
  • Social science

Richard Freeman mainly focuses on Public administration, Labour economics, Public policy, Demographic economics and Health policy. In the field of Public administration, his study on Policy analysis overlaps with subjects such as Policy making. His Labour economics research includes themes of Marketization, Production, Unemployment and Goods and services.

His Unemployment research includes elements of Social protection, Labor mobility, Informal sector, Collective bargaining and Labor relations. As a part of the same scientific study, Richard Freeman usually deals with the Public policy, concentrating on Public relations and frequently concerns with Content analysis. His study looks at the intersection of Health policy and topics like Health promotion with Health administration.

His most cited work include:

  • Marketization of household production and the EU–US gap in work (154 citations)
  • The Impact of Industrial Relations Legislation on British Union Density (145 citations)
  • DOES GLOBALIZATION OF THE SCIENTIFIC/ENGINEERING WORKFORCE THREATEN U.S. ECONOMIC LEADERSHIP? (140 citations)

What are the main themes of his work throughout his whole career to date?

His primary areas of investigation include Labour economics, Wage, Demographic economics, Public administration and Health policy. His biological study spans a wide range of topics, including Private sector and Unemployment. His studies in Wage integrate themes in fields like Productivity, Minimum wage and Service.

His study in Demographic economics is interdisciplinary in nature, drawing from both Higher education, Value and Multinational corporation. As a part of the same scientific family, Richard Freeman mostly works in the field of Public administration, focusing on Politics and, on occasion, Power and Public relations. In his research on the topic of Health policy, Welfare state is strongly related with Context.

He most often published in these fields:

  • Labour economics (37.72%)
  • Wage (17.37%)
  • Demographic economics (16.17%)

What were the highlights of his more recent work (between 2010-2020)?

  • Public administration (11.98%)
  • Politics (7.78%)
  • Mental health (4.19%)

In recent papers he was focusing on the following fields of study:

His primary areas of study are Public administration, Politics, Mental health, Public relations and Action. His Public administration research is multidisciplinary, incorporating perspectives in Policy studies, Global politics, Declaration and Health policy. His Politics research integrates issues from Critical theory, Interrogation and Power.

His Mental health study incorporates themes from Nursing and Health administration. The various areas that he examines in his Public relations study include Government, Promotion and Content analysis. His Action study combines topics in areas such as Production and Knowledge policy.

Between 2010 and 2020, his most popular works were:

  • Documents, Practices and Policy (70 citations)
  • The Practice of Policy Making (42 citations)
  • Implementing recovery: an analysis of the key technologies in Scotland. (39 citations)

In his most recent research, the most cited papers focused on:

  • Law
  • Capitalism
  • Social science

His primary scientific interests are in Mental health, Public relations, Public administration, Policy analysis and Order. Richard Freeman combines subjects such as Nursing, Promotion and Health administration with his study of Mental health. His research in Public relations intersects with topics in Government, Content analysis and Public policy.

His Public administration study combines topics from a wide range of disciplines, such as Policy studies and Health policy. His Policy analysis research incorporates elements of Contrast and Heuristic. His research links Politics with Order.

Best Publications

  • Model for end-stage liver disease (MELD) and allocation of donor livers

    Russell Wiesner;Erick Edwards;Richard Freeman;Ann Harper

  • Efficacy and safety of valganciclovir vs. oral ganciclovir for prevention of cytomegalovirus disease in solid organ transplant recipients.

    Carlos Paya;Atul Humar;Ed Dominguez;Kenneth Washburn

  • The survival benefit of liver transplantation.

    Robert M. Merion;Douglas E. Schaubel;Dawn M. Dykstra;Richard B. Freeman

  • The new liver allocation system: Moving toward evidence‐based transplantation policy

    Richard B. Freeman;Russell H. Wiesner;Ann Harper;Sue V. McDiarmid

  • Results of the first year of the new liver allocation plan.

    Richard B. Freeman;Russell H. Wiesner;Erick Edwards;Ann Harper

  • Report of a national conference on liver allocation in patients with hepatocellular carcinoma in the United States.

    Elizabeth A. Pomfret;Kenneth Washburn;Christoph Wald;Michael A. Nalesnik

  • Valganciclovir Results in Improved Oral Absorption of Ganciclovir in Liver Transplant Recipients

    Mark D. Pescovitz;John Rabkin;Robert M. Merion;Carlos V. Paya

  • Report of the Crystal City Meeting to Maximize the Use of Organs Recovered from the Cadaver Donor

    Bruce R. Rosengard;Sandy Feng;Edward J. Alfrey;Jonathan G. Zaroff

  • ASTS recommended practice guidelines for controlled donation after cardiac death organ procurement and transplantation.

    D. J. Reich;D. C. Mulligan;P. L. Abt;T. L. Pruett

  • Epstein-Barr Virus–Infected Resting Memory B Cells, Not Proliferating Lymphoblasts, Accumulate in the Peripheral Blood of Immunosuppressed Patients

    Gregory J. Babcock;Lisa L. Decker;Richard B. Freeman;David A. Thorley-Lawson

  • Cytomegalovirus in transplantation - challenging the status quo

    Jay A Fishman;Vincent Emery;Richard Freeman;Manuel Pascual

  • Report of the Paris consensus meeting on expanded criteria donors in liver transplantation

    François Durand;John F. Renz;Barbara Alkofer;Patrizia Burra

  • Hepatocellular carcinoma patients are advantaged in the current liver transplant allocation system.

    K. Washburn;E. Edwards;A. Harper;R. B. Freeman

  • Liver transplantation for hepatocellular cancer: The impact of the MELD allocation policy

    Russell H. Wiesner;Richard B. Freeman;David C. Mulligan

  • Liver and intestine transplantation in the United States, 1997-2006.

    R. B. Freeman;Diane E Steffick;Mary K. Guidinger;D. G. Farmer

  • The Kaposi sarcoma-associated herpesvirus (KSHV) is present as an intact latent genome in KS tissue but replicates in the peripheral blood mononuclear cells of KS patients.

    Lisa L. Decker;Premalata Shankar;Gulfaraz Khan;Richard B. Freeman

  • A randomized double-blind comparative study of mycophenolate mofetil and azathioprine in combination with cyclosporine and corticosteroids in primary liver transplant recipients.

    Russell Wiesner;John Rabkin;Goran Klintmalm;Sue McDiarmid

  • Marketization of household production and the EU–US gap in work

    Richard B. Freeman;Ronald Schettkat

  • Preemptive ganciclovir therapy to prevent cytomegalovirus disease, in cytomegalovirus antibody-positive renal transplant recipients. A randomized controlled trial

    P. L. Hibberd;N. E. Tolkoff-Rubin;D. Conti;F. Stuart

  • Improving liver allocation: MELD and PELD.

    Richard B. Freeman;Russell H. Wiesner;John P. Roberts;Suzanne McDiarmid

Frequent Co-Authors

David R. Snydman
David R. Snydman Tufts Medical Center
Robert M. Merion
Robert M. Merion University of Michigan–Ann Arbor
Douglas L. Kruse
Douglas L. Kruse Rutgers, The State University of New Jersey
John P. Roberts
John P. Roberts University of California, San Francisco
John L. Griffith
John L. Griffith Northeastern University
Robin Ruthazer
Robin Ruthazer Tufts Medical Center
Francis L. Delmonico
Francis L. Delmonico Harvard University
David G. Blanchflower
David G. Blanchflower Dartmouth College
Joseph R. Blasi
Joseph R. Blasi Rutgers, The State University of New Jersey

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring alternative healthcare career paths is a smart move for students interested in medicine but seeking flexibility or different entry points. Online degree options make it easier to balance studies with existing commitments while advancing your credentials.

For those interested in leadership roles, cheap mha programs offer an affordable way to earn a Master’s in Healthcare Administration, opening doors to management positions in hospitals and clinics. Nursing professionals looking to move into advanced practice can benefit from cheap dnp online programs that lead to a Doctor of Nursing Practice degree without the need to relocate.

Pharmacists are in high demand, and accredited online pharmacy school programs allow students to earn their doctorate with increased affordability and convenience. Alternatively, tech-focused students can consider a bachelor of health information management online, preparing them for data-driven roles in healthcare systems management.

Whether your interests lie in administration, patient care, pharmacy, or informatics, these accessible online degrees create new opportunities for rewarding healthcare careers.

Best Scientists Citing Richard Freeman

Trending Scientists

Recently Published Articles